Methane

Methane

SCHEMBL4169772

C.Oc1ccc2c(c1)OCO2

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.95
CALM1 P0DP23 2/20 0.55
ALDH1A1 P00352 4/20 0.50
MAPK1 P28482 1/20 0.50
MEN1 O00255 2/20 0.47
MAPT P10636 2/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 1/20 0.47
NPC1 O15118 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
GAA P10253 1/20 0.47
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29510426 0.98 CYP3A4 (1.00) CYP3A4CALM1ALDH1A1MAPK1MEN1
SCHEMBL20959 0.98 CYP3A4 (1.00) CYP3A4CALM1ALDH1A1MAPK1MEN1
Formaldehyde SCHEMBL27904688 0.91 CYP3A4 (0.87) CYP3A4CALM1ALDH1A1MAPK1MEN1
Alcohol SCHEMBL8027238 0.87 CYP3A4 (0.80) CYP3A4CALM1ALDH1A1MAPK1MEN1
Phosphoric Acid SCHEMBL2592727 0.87 CYP3A4 (0.80) CYP3A4CALM1ALDH1A1MAPK1MEN1
Formic Acid SCHEMBL7109456 0.87 CYP3A4 (0.80) CYP3A4CALM1ALDH1A1MAPK1MEN1
Catechol SCHEMBL5622502 0.87 CYP3A4 (0.80) CYP3A4CALM1ALDH1A1MAPK1MEN1
Acetic Acid SCHEMBL28643630 0.86 CYP3A4 (0.77) CYP3A4CALM1ALDH1A1MAPK1MEN1
SCHEMBL25351591 0.84 CYP3A4 (0.75) CYP3A4CALM1ALDH1A1MAPK1MEN1
SCHEMBL746125 0.83 CYP3A4 (0.74) CYP3A4ALDH1A1MAPK1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233913-A1 OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) 2009-09-17 US claimed
US-20090233913-A1 OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233913-A1 OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS GABRA2, GABRA3, GABRB2 CYP3A4 320/4885CALM1 905/4885ALDH1A1 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.